DK1254905T3 - 4-(2-pyridyl)piperiziner med 5HT7 receptoragonistaktivitet - Google Patents
4-(2-pyridyl)piperiziner med 5HT7 receptoragonistaktivitetInfo
- Publication number
- DK1254905T3 DK1254905T3 DK02252903T DK02252903T DK1254905T3 DK 1254905 T3 DK1254905 T3 DK 1254905T3 DK 02252903 T DK02252903 T DK 02252903T DK 02252903 T DK02252903 T DK 02252903T DK 1254905 T3 DK1254905 T3 DK 1254905T3
- Authority
- DK
- Denmark
- Prior art keywords
- piperizines
- pyridyl
- receptor agonist
- agonist activity
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28817801P | 2001-05-02 | 2001-05-02 | |
| US28946601P | 2001-05-08 | 2001-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1254905T3 true DK1254905T3 (da) | 2004-03-29 |
Family
ID=26964875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02252903T DK1254905T3 (da) | 2001-05-02 | 2002-04-24 | 4-(2-pyridyl)piperiziner med 5HT7 receptoragonistaktivitet |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20030008880A1 (da) |
| EP (1) | EP1254905B1 (da) |
| JP (1) | JP2003012648A (da) |
| AT (1) | ATE256678T1 (da) |
| BR (1) | BR0201569A (da) |
| CA (1) | CA2384344A1 (da) |
| DE (1) | DE60200135T2 (da) |
| DK (1) | DK1254905T3 (da) |
| ES (1) | ES2210218T3 (da) |
| MX (1) | MXPA02004409A (da) |
| PT (1) | PT1254905E (da) |
| TR (1) | TR200400027T4 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003271174A1 (en) | 2003-10-10 | 2005-04-27 | Chugai Seiyaku Kabushiki Kaisha | Double specific antibodies substituting for functional protein |
| EP1693448A4 (en) | 2003-10-14 | 2008-03-05 | Chugai Pharmaceutical Co Ltd | DOUBLE SPECIFICITY ANTIBODY FOR FUNCTIONAL PROTEIN SUBSTITUTION |
| AR048112A1 (es) * | 2004-03-25 | 2006-03-29 | Solvay Pharm Bv | Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor |
| US20050215551A1 (en) * | 2004-03-25 | 2005-09-29 | Solvay Pharmaceuticals B.V. | 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders |
| AR049478A1 (es) * | 2004-03-25 | 2006-08-09 | Solvay Pharm Bv | Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas. |
| US20060013874A1 (en) * | 2004-07-15 | 2006-01-19 | Solvay Pharmaceuticals B.V. | Extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one |
| TW200914020A (en) * | 2007-08-28 | 2009-04-01 | Lilly Co Eli | Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists |
| PT2201002E (pt) | 2007-10-12 | 2012-04-27 | Lilly Co Eli | Antagonistas de receptores 5-ht7 |
| EP2149373A1 (en) * | 2008-08-01 | 2010-02-03 | Laboratorios Del. Dr. Esteve, S.A. | 5HT7 receptor ligands and compositions comprising the same |
| EP3145906B1 (en) * | 2014-05-19 | 2023-10-04 | Northeastern University | Serotonin receptor-targeting compounds |
| DE102018120011B4 (de) | 2018-08-16 | 2022-06-15 | Trumpf Laser Und Systemtechnik Gmbh | Schweißverfahren zum Verbinden eines transparenten, aluminiumoxidhaltigen ersten Substrats mit einem opaken zweiten Substrat |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9612885D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| FR2761067B1 (fr) * | 1997-03-20 | 1999-04-23 | Synthelabo | Derives de quinolein-2-(1h)-one, leur preparation et leur application en therapeutique |
| GB9710523D0 (en) * | 1997-05-23 | 1997-07-16 | Smithkline Beecham Plc | Novel compounds |
-
2002
- 2002-02-13 US US10/075,910 patent/US20030008880A1/en not_active Abandoned
- 2002-04-19 JP JP2002117420A patent/JP2003012648A/ja active Pending
- 2002-04-24 PT PT02252903T patent/PT1254905E/pt unknown
- 2002-04-24 EP EP02252903A patent/EP1254905B1/en not_active Expired - Lifetime
- 2002-04-24 DK DK02252903T patent/DK1254905T3/da active
- 2002-04-24 DE DE60200135T patent/DE60200135T2/de not_active Expired - Fee Related
- 2002-04-24 AT AT02252903T patent/ATE256678T1/de not_active IP Right Cessation
- 2002-04-24 ES ES02252903T patent/ES2210218T3/es not_active Expired - Lifetime
- 2002-04-24 TR TR2004/00027T patent/TR200400027T4/xx unknown
- 2002-04-30 MX MXPA02004409A patent/MXPA02004409A/es active IP Right Grant
- 2002-04-30 CA CA002384344A patent/CA2384344A1/en not_active Abandoned
- 2002-05-02 BR BR0201569-2A patent/BR0201569A/pt not_active IP Right Cessation
-
2003
- 2003-07-10 US US10/617,967 patent/US7009051B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2384344A1 (en) | 2002-11-02 |
| ATE256678T1 (de) | 2004-01-15 |
| TR200400027T4 (tr) | 2004-03-22 |
| MXPA02004409A (es) | 2002-11-14 |
| US20040014769A1 (en) | 2004-01-22 |
| DE60200135D1 (de) | 2004-01-29 |
| ES2210218T3 (es) | 2004-07-01 |
| JP2003012648A (ja) | 2003-01-15 |
| EP1254905A1 (en) | 2002-11-06 |
| US20030008880A1 (en) | 2003-01-09 |
| BR0201569A (pt) | 2003-06-10 |
| US7009051B2 (en) | 2006-03-07 |
| EP1254905B1 (en) | 2003-12-17 |
| DE60200135T2 (de) | 2004-06-03 |
| PT1254905E (pt) | 2004-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0675886T3 (da) | Aminomethylensubstituerede ikke-aromatiske heterocykler og deres anvendelse som substance P-antagonister | |
| DK1474395T3 (da) | Nicotinamidderivater, der er nyttige som p38-inhibitorer | |
| DE60221098D1 (de) | Kondensierte heterocyclische derivate | |
| NO20064238L (no) | Imidazolinderivater med CB1 agonistlsk aktivitet | |
| ES2194960T3 (es) | N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f. | |
| ATE228119T1 (de) | Heterocyclische carboxamide | |
| DE602006010540D1 (de) | (3,4-dihydro-chinazolin-2-yl)-(2-aryloxy-ethyl)-amine mit aktivität am 5-ht-rezeptor | |
| DK1254905T3 (da) | 4-(2-pyridyl)piperiziner med 5HT7 receptoragonistaktivitet | |
| CY1108837T1 (el) | ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5 | |
| ATE240326T1 (de) | Pyrrolo-(3,2-b)pyridine und ihre verwendung als 5-ht1f agonisten | |
| FI905957A0 (fi) | Foerfarande foer framstaellning av substituerade cyklohexener, som verkar pao det centrala nervsystemet. | |
| DE502004007387D1 (de) | Triazolverbindungen und ihre therapeutische verwendung | |
| EA200501579A1 (ru) | Производные 4-(2-фенилсульфанилфенил)-1,2,3,6-тетрагидропиридина в качестве ингибиторов повторного поглощения серотонина | |
| DE60224509D1 (de) | Imidazolderivate verwendbar als histamin h3 rezeptorliganden | |
| EA200602081A1 (ru) | Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7 | |
| ATE252546T1 (de) | 3-(3-hydroxyphenyl)-3-amino-propionamidderivate | |
| NO20004075L (no) | Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister | |
| DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
| DK1421086T3 (da) | 2-(Aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl-derivater med antipsykotisk aktivitet | |
| DE60214558D1 (de) | 2-(AMINOMETHYL)TETRAHYDRO-9-OXA-1,3-DIAZACYCLOPENTAcAÜNAPHTHALINYLDERIVATE MIT ANTIPSYCHOTISCHER WIRKUNG |